Ventec Life Systems’ VOCSN unified respiratory system has been selected as winner of the “Best New Therapeutic Technology Solution” award as part of the annual MedTech Breakthrough Awards program, according to a MedTech press announcement.

 

VOCSN was selected as a MedTech Breakthrough Award winner for “breaking through” a traditionally complex system of disparate respiratory therapeutic devices. In treating respiratory issues, caregivers have historically been tasked with managing up to five separate devices with their own complex operating systems.

VOCSN is the first portable unified respiratory system that integrates five product technologies into a single device: ventilation, oxygen therapy, cough assist, suction, and nebulization. The device is 70% lighter and smaller than existing machines and includes eight pending patents, according to the company.

The device provides an integrated solution that is designed to improve care for patients with neuromuscular disease (eg Muscular Dystrophies, ALS), impaired lung function (eg COPD, cystic fibrosis, lung cancers, emphysema), spinal cord injury, and pediatric development complication (eg premature births, chronic lung disease).

“Companies like Ventec are truly setting the standard for innovation and creativity with health and medical technology,” said James Johnson, managing director, MedTech Breakthrough. “The judges were impressed with the ingenuity displayed in designing VOCSN as a groundbreaking portable life support device that combines five respiratory therapies – Ventilation, Oxygen, Cough, Suction, and Nebulization into a single unified system. We congratulate Ventec on their well-deserved industry recognition.”

“It is an incredible honor to be selected among the best from the thousands of MedTech Breakthrough Award entries this year,” stated Doug DeVries, Founder and Chief Executive Officer at Ventec. “We are pleased to have VOCSN recognized by MedTech Breakthrough and consider it a testament to the hard work and passion of the Ventec Team to improve the lives of patients and caregivers.”